CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both important.

Research output: Contribution to journalEditorial

3 Scopus citations
Original languageEnglish
Pages (from-to)691-692
Number of pages2
JournalArchives of neurology
Volume69
Issue number6
StatePublished - Jun 2012

Cite this